Despite the fact that
biopharmaceuticals offer significant profit margins, innovator companies are
plagued by high costs of development, complex production protocols and special
procedures and equipment for fill / finish operations. Consequently, a number
of drug manufacturers have demonstrated a preference for outsourcing fill /
finish operations of such products.
To order this 480+ page report, which features 350+ figures
and 260+ tables, please visit this https://www.rootsanalysis.com/reports/256/request-sample.html
The USD 4.2 billion
(by 2030) financial opportunity within the biologics fill / finish services market
has been analyzed across the following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
The Biologics
Fill / Finish Services Market, 2020-2030 report features the following companies, which we
identified to be key players in this domain:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
Table of Contents
1. Preface
4. Competitive Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North
America: Company Profiles
7. Biologics Fill / Finish Service Providers in Europe:
Company Profiles
8. Biologics Fill / Finish Service Providers in
Asia-Pacific: Company Profiles
9. Partnerships and Collaborations
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Biologics Manufacturing and Fill / Finish: Key
Performance Indicator Analysis
14. Market Sizing and Opportunity Analysis
15. Future Growth Opportunities
16. Case Study: Robotic Systems in Fill / Finish Operations
17. Case Study: Ready-to-Use Packaging Components in
Aseptic Fill / Finish Operations
18. Conclusion
19. Interview Transcripts
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
